Диссертация (Аргоноплазменная энергия в лечении доброкачественных опухолей и опухолевидных образований яичников), страница 24
Описание файла
Файл "Диссертация" внутри архива находится в папке "Аргоноплазменная энергия в лечении доброкачественных опухолей и опухолевидных образований яичников". PDF-файл из архива "Аргоноплазменная энергия в лечении доброкачественных опухолей и опухолевидных образований яичников", который расположен в категории "". Всё это находится в предмете "медицина" из Аспирантура и докторантура, которые можно найти в файловом архиве РУДН. Не смотря на прямую связь этого архива с РУДН, его также можно найти и в других разделах. , а ещё этот архив представляет собой кандидатскую диссертацию, поэтому ещё представлен в разделе всех диссертаций на соискание учёной степени кандидата медицинских наук.
Просмотр PDF-файла онлайн
Текст 24 страницы из PDF
– 2014. – V. 9, № 5. – e98174. doi:10.1371/journal.pone.0098174. eCollection 2014.63. Anti-Müllerian hormone as a marker of premature ovarian aging inautoimmune thyroid disease / F. Saglam, E. D. Onal, R. Ersoy [et al.] // Gynecol.Endocrinol. – 2015. – V. 31, № 2. – Р. 165-168. Doi: 10.3109/09513590.2014.973391.Epub 2014 Oct 16. PMID: 25319839.64. Anti-Mullerian hormone is a better marker than inhibin B, follicle stimulatinghormone, estradiol or antral follicle count in predicting the outcome of in vitrofertilization / C. Kunt, G.
Ozaksit, R. Keskin Kurt [et al.] // Arch. Gynecol. Obstet. –2011. – V. 283, № 6. – Р. 1415-1421.65. Antral follicle count as a predictor of ovarian responsiveness in women withendometriomas or with a history of surgery for endometriomas / L. Benaglia,G. Candotti, A. Busnelli [et al.] // Fertil. Steril. – 2015. – V. 103, № 6. – Р. 15441550.e1-3. Doi: 10.1016/j.fertnstert.2015.03.013. Epub 2015 Apr 29.66. Assessment of ovarian reserve in patients with ovarian endometriosisfollowing laparoscopic enucleation of a cyst accompanied by CO₂ laser ablation orelectroablation / E.
Posadzka, A. Nocuń, R. Jach [et al.] // Przegl. Lek. – 2016. – V. 73,№ 1. – P. 6–10.67. Association between Endometriomas and Ovarian Cancer : Preventive Effectof Inhibiting Ovulation and Menstruation during Reproductive Life / G. Grandi,A. Toss, L. Cortesi [et al.] // Biomed. Res.
Int. – 2015. – V. 751571. Doi:10.1155/2015/751571. Epub 2015 Aug 30.68. Aznaurova, Y. B. Molecular aspects of development and regulation ofendometriosis / Y. B. Aznaurova, M. B. Zhumataev, T. K. Roberts // Reprod. Biol.Endocrinol. – 2014. – V. 13, № 12. – Р. 50. doi: 10.1186/1477-7827-12-50.69. Broer, S.L. Anti-Müllerian hormone: ovarian reserve testing and its potentialclinical implications / S. L.
Broer, F. J. Broekmans, J. S. Laven // Hum. Reprod.Update. – 2014. – V. 20, № 5. – Р. 688-701.70. Bukovsky, A. Immunoregulation of follicular renewal, selection, POF, andmenopause in vivo, vs. neo-oogenesis in vitro, POF and ovarian infertility treatment,129and a clinical trial / A. Bukovsky, R. Michael // Reprod. Biol. Endocrinol. – 2012. –V.
10, № 97. Published online 2012 Nov 23. doi: 10.1186/1477-7827-10-97.71. Camlin, N.J. Through the smoke: use of in vivo and in vitro cigarette smokingmodels to elucidate its effect on female fertility / N. J. Camlin, E. A. McLaughlin,J. E. Holt // Toxicol. Appl. Pharmacol. – 2014. – V. 281, № 3. – Р. 266-275. Doi:10.1016/j.taap.2014.10.010. Epub 2014 Oct 27.72. Check, J. H. Understanding the physiology of folliculogenesis serves as thefoundation for perfecting diagnosis and treatment of ovulatory defects / J.H.
Check //Clinical and experimental obstetrics and gynecology. – 2012. – V. 39, № 3. – Р. 273–279.73. Christiana, M. Serum antimüllerian hormone in healthy premenopausalwomen / M. Christiana, M. D. Shaw, M. S. Frank // Fertil. Steril. – 2011. – V. 30, № 95.– Р. 2718-2721.74. Circulating AMH reflects ovarian morphology by magnetic resonanceimaging and 3D ultrasound in 121 healthy girls / С. Р.
Hagen, A. Mouritsen,M. G. Mieritz [et al.] // J. Clin. Endocrinol. Metab. – 2015. – V. 100, № 3. – Р. 880-890.Doi: 10.1210/jc.2014-3336. Epub 2014 Dec 8. PMID: 25485726.75. Coric, M. Inhibin B for assessment of ovarian reserve after laparoscopictreatment of ovarian endometriomas / M. Coric, T. Goluza, J. Juras // Int. J. Gynaecol.Obstet. – 2012. – V. 116, № 2. – Р. 169-70.
Doi: 10.1016/j.ijgo.2011.09.014.76. Dan, H. Laparoscopic ovarian cystectomy versus fenestration/coagulation orlaser vaporization for the treatment of endometriomas : a meta-analysis of randomizedcontrolled trials / H. Dan, F. Limin // Gynecol. Obstet. Invest. – 2013. – V. 76, № 2. –Р. 75-82. Doi: 10.1159/000351165. Epub 2013 Jun 6.77. Dayal, M. Anti-mullerian hormone : a new marker of ovarian function /M.
Dayal, S. Sagar, A. Chaurasia // Obstet. Gynaecol. India. – 2014. – V. 64, № 2. –Р. 130-133.78. Decreased anti-Müllerian hormone concentration in follicular fluid of femalesmokers undergoing artificial reproductive techniques / A. Fuentes , A. Muñoz,130R. Pommer [et al.] // Chemosphere. – 2012. – V. 88, №4. – P. 403–406. doi:10.1016/j.chemosphere.2012.02.054. Epub 2012 Mar 23.79. Deep pelvic endometriosis negatively affects ovarian reserve and the numberof oocytes retrieved for in vitro fertilization / E.
Papaleo, J. Ottolina, P. Viganò [et al.] //Acta. Obstet. Gynecol. Scand. – 2011. – V. 90, № 8. – Р. 878-884. Doi: 10.1111/j.16000412.2011.01161.x. Epub 2011 Jun 14.80. Del Carmen, M. G. Evidence for the Relationship Between Endometriosis andEpithelial Ovarian Cancer / M. G. del Carmen // Obstet. Gynecol. Surv.
– 2015. – V. 70,№ 9. – Р. 587-595. Doi: 10.1097/OGX.0000000000000218.81. Determining an anti-mullerian hormone cutoff level to predict clinicalpregnancy following in vitro fertilization in women with severely diminished ovarianreserve / Z. Merhi, A. Zapantis, D. S. Berger [et al.] // Assist. Reprod. Genet. – 2013. –V. 30, № 10. – P. 1361-1365.82. Dewailly, D.
The physiology and clinical utility of anti-Mullerian hormone inwomen / D. Dewailly, C. Y. Andersen, A. Balen // Hum. Reprod. Update. – 2014. –V. 20. – Р. 3370-3385.83. Dillon, K. E. What is normal ovarian reserve ? / K. E. Dillon, C. R. Gracia //Semin. Reprod. Med. – 2013.–V. 31, № 6. – Р. 427-436.84. Ding, W. Impact on ovarian reserve of haemostasis by bipolar coagulationversus suture following surgical stripping of ovarian endometrioma : a meta-analysis /W. Ding, M. Li, Y. Teng // Reprod.
Biomed. Online. – 2015. Рii: S. 14726483(15)00105-4.85. Dubuisson, J. Management of presumed benign giant ovarian cysts: aminimally invasive technique using the Alexis Laparoscopic System / J. Dubuisson,A. Fehlmann, P. Petignat // J. Minim. Invasive. Gynecol. – 2015. – V. 22, № 4. –Р. 540. doi: 10.1016/j.jmig.2015.01.027. Epub 2015 Feb 4.86. Ebrahimi, M.
The role of autoimmunity in premature ovarian failure /M. Ebrahimi, F. A. Asbagh // Iran. J. Reprod. Med. – 2015. – V. 13, № 8. – P.461–472.PMCID: PMC4637110.13187. Effect of age and stage of endometriosis on ovarian follicular loss duringlaparoscopic cystectomy for endometrioma / H. K. Oh, J. I. Sin, J. H. Kim [et al.] // Int.J.Gynaecol.Obstet.–2011.–V.114,№2.–Р.128-32.Doi:10.1016/j.ijgo.2011.02.011.
Epub 2011 Jun 17.88. Effects of bipolar electrocoagulation versus suture after laparoscopic excisionof ovarian endometrioma on the ovarian reserve and outcome of in vitro fertilization /A. Takashima, N. Takeshita, K. Otaka [et al.] // J. Obstet. Gynaecol. Res. – 2013. –V. 39, № 7. – Р. 1246-1252. Doi: 10.1111/jog.12056.89. Effect of hemostatic method on ovarian reserve following laparoscopicendometrioma excision / B. Ata, E.
Turkgeldi, A. Seyhan [et al.] // J. Minim. InvasiveGynecol. – 2015. – V. 22, № 3. – Р. 363-372. Doi: 10.1016/j.jmig.2014.12.168. Epub2015 Jan 5. Review.90. Effects of Letrozole-HMG and Clomiphene-HMG on Incidence of LuteinizedUnruptured Follicle Syndrome in Infertile Women Undergoing Induction Ovulation andIntrauterine Insemination: A Randomised Trial / A. Azmoodeh, M. Pejman Manesh,F. Akbari Asbagh [et al.] // Glob. J. Health Sci. – 2015. – V. 8, № 4. – 244–52. doi:10.5539/gjhs.v8n4p244.91. Effects of ovarian endometrioma on embryo quality / S.L. Reinblatt, L. Ishai,F. Shehata [et al.] // Fertil.
Steril. – 2011. – V. 95, № 8. – P. 2700-2702. Doi:10.1016/j.fertnstert.2011.03.002. Epub 2011 Mar 27.92. Effect of two laparoscopic techniques for treatment of ovarian endometriomaon ovarian reserve / J. Georgievska, S. Sapunov, S. Cekovska [et al.] // Med. Arch. –2015. – V. 69, № 2. – Р. 88-90. Doi: 10.5455/medarh.2015.69.88-90.
Epub 2015 Apr 6.93. Effect on ovarian reserve of hemostasis by bipolarcoagulation versus sutureduring laparoendoscopic single-site cystectomy for ovarian endometriomas / T. Song,W. Y. Kim, K. W. Lee // J. Minim. Invasive Gynecol. – 2015. – V. 22, № 3. – Р. 415420. Doi: 10.1016/j.jmig.2014.11.002.
Epub 2014 Nov 13.94. Efficacy of bronchoscopic therapies for bronchial mucoepidermoid carcinomain children: results from six patients // H. Wang, J. Zhang, D. Li [et al.] // Tumori. –2015. – V. 101, № 1. – Р. 52-56. Doi: 10.5301/tj.5000213. Epub 2015 Feb 6.13295. Endometriomas as a possible cause of reduced ovarian reserve in women withendometriosis / M. Kitajima, S. Defrère, M. M.
Dolmans [et al.] // Fertil. Steril. – 2011.– V. 96, № 3. – Р. 685-691. Doi: 10.1016/j.fertnstert.2011.06.064. Epub 2011 Jul 29.96. Endometrioma size is a relevant factor in selection of the most appropriatesurgical technique : a prospective randomized preliminary study / P. Giampaolino,G. Bifulco, A. Di Spiezio Sardo [et al.] // Eur.
J. Obstet. Gynecol. Reprod. Biol. – 2015.– № 195. – Р. 88-93.97. Epidemiology of presumed benign ovarian tumors / C. Mimoun, X. Fritel,A. Fauconnier [et al.] // J. Gynecol. Obstet. Biol. Reprod (Paris). – 2013. – V. 42, №8. –Р. 722-729.98. ESHRE guideline : management of women with endometriosis /G.A. Dunselman, N. Vermeulen, C.
Becker [et al.] // Hum. Reprod. – 2014. – V. 29,№3. – Р. 400-412. Doi: 10.1093/humrep/det457. Epub 2014 Jan 15.99. Evaluation of a risk of malignancy i ndex based on serum CA-125, ultrasoundfindings and menopausal status in the pre-operative diagnosis of pelvic masses /S. Tingulstad, B. Hagen, F. E. Skjeldestad [et al.] // Brit. J. Obstet. Gynaecol. – 1996. –V. 103, № 8.
– P. 826-831.100. Evidence of a genetic link between endometriosis and ovarian cancer /A.W. Lee, C. Templeman, D.A. Stram [et al.] // Fertil. Steril. – 2016. – V. 105, № 1. –Р. 35-43.e10. Doi: 10.1016/j.fertnstert.2015.09.023. Epub 2015 Oct 23. PMID:26477498.101. Farghaly, S.A. Current diagnosis and management of ovarian cysts /S.A. Farghaly // Clin.
Exp. Obstet. Gynecol. – 2014. – V. 41, № 6. – Р. 609-612.Review. PMID: 25551948.102. Female Reproductive Decline Is Determined by Remaining Ovarian Reserveand Age / P. Wilkosz, G. D. Greggains, T. G. Tanbo [et al.] // PLoS One. – 2014. –V. 9,№10:Р:e108343.Publishedonline2014October13.Doi: 10.1371/journal.pone.0108343.103. Fine needle aspiration cytology of ovarian tumors with histologicalcorrelation / A.
Bandyopadhyay, J. Chakraborty, A. R. Chowdhury [et al.] // J. Cytol. –1332012. – V. 29, № 1. – Р. 35-40. Doi: 10.4103/0970-9371.93218. PMCID:PMC3307449.104. Flyckt, R. Endometriomas and assisted reproductive technology / R. Flyckt,E. Soto, T. Falcone // Semin. Reprod. Med.